Last reviewed · How we verify
NCT06933667
Kimel Family Centre for Brain Health and Wellness
NA trial testing Physical Activity in Prevention in 450 participants. Currently enrolling.
31 August 2027
Quick facts
| Lead sponsor | Baycrest |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 450 |
| Start date | 26 March 2024 |
| Primary completion | 31 August 2027 |
| Estimated completion | 31 August 2027 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Physical Activity
- Brain-healthy Eating
- Cognitive Engagement
- Social Connections
- Mental Wellbeing
Conditions studied
- Prevention — all drugs for Prevention →
- Dementia — all drugs for Dementia →
Sponsor
Baycrest — full company profile →
Who can join
50 and older, any sex, with Prevention or Dementia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Participants (n=450; aged 50+; without a diagnosis of dementia; sufficiently fluent in English to complete the assessments and engage in programming) receive a comprehensive dementia risk assessment, including nonmodifiable and modifiable risk factors, from which they receive a Personalized Dementia Risk Report and Program Strategy, indicating their health conditions increasing and their risk level in five modifiable risk domains: physical activity, brain- healthy eating, cognitive engagement, social connections, and mental wellbeing. Equipped with this information, participants enroll in programs within the Centre to address their risk factors. Changes to their dementia risk, cognition, and Personalized Program Strategy are communicated through re-assessments of risk factors every six months (risk and cognition) and every year (comprehensive assessment).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06933667
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Physical Activity
Trials testing the same drug.
- NCT07480811 — The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD · NA · not yet recruiting
- NCT07125053 — COPD Resources, Education, and Activity Designed for You Study · NA · recruiting
- NCT07099040 — Community-based Multi-domain Intervention to Detect and Delay Cognitive Decline in Community-dwelling Older Adults: A Pi · NA · not yet recruiting
- NCT06948500 — Effectiveness of an IVR-based Therapeutic Exercise Program With Altered Visual Feedback in Fibromyalgia Patients · NA · recruiting
- NCT06822387 — Health Without Barriers/Salud Sin Barreras- Northern Colorado · NA · recruiting
Other recruiting trials for Prevention
Currently open trials in the same condition.
- NCT07511491 — Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section · NA · recruiting
- NCT07248280 — Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatie · Phase 3 · recruiting
- NCT07382583 — Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the P · recruiting
- NCT07498530 — Virtual Assistant for Exercise Adherence in Older ADULTS · NA · recruiting
- NCT06682494 — Enhancing Oral Cancer Awareness · NA · recruiting
Other Baycrest trials
Trials by the same sponsor.
- NCT05509387 — Investigating if a Stronger tDCS Intensity is More Effective for Improving Naming Ability in People Living With Alzheime · NA · recruiting
- NCT05508841 — Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation · NA · recruiting
- NCT05347966 — Brain Health Support Program · NA · completed
- NCT05167045 — A Pilot Study for the Brain Health Support Program · completed
- NCT04966260 — Virtual Reality Therapy to Improve Physical and Psychological Symptoms and Quality of Life for End-of-life Patients on a · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06933667 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Baycrest
- Last refreshed: 18 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06933667.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing